Literature DB >> 15300247

Deliberate removal of T cell help improves virus-neutralizing antibody production.

Mike Recher1, Karl S Lang, Lukas Hunziker, Stefan Freigang, Bruno Eschli, Nicola L Harris, Alexander Navarini, Beatrice M Senn, Katja Fink, Marius Lötscher, Lars Hangartner, Raphaël Zellweger, Martin Hersberger, Alexandre Theocharides, Hans Hengartner, Rolf M Zinkernagel.   

Abstract

The B cell response to lymphocytic choriomeningitis virus is characterized by a CD4(+) T cell-dependent polyclonal hypergammaglobulinemia and delayed formation of virus-specific neutralizing antibodies. Here we provide evidence that, paradoxically, because of polyclonal B cell activation, virus-specific T cell help impairs the induction of neutralizing antibody responses. Experimental reduction in CD4(+) T cell help in vivo resulted in potent neutralizing antibody responses without impairment of CD8(+) T cell activity. These unexpected consequences of polyclonal B cell activation may affect vaccine strategies and the treatment of clinically relevant chronic bacterial, parasitic and viral infections in which hypergammaglobulinemia is regularly found.

Entities:  

Mesh:

Year:  2004        PMID: 15300247     DOI: 10.1038/ni1102

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  37 in total

1.  HIV neutralizing antibodies: clinical correlates and implications for vaccines.

Authors:  Nicole A Doria-Rose
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

2.  Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239.

Authors:  Nancy A Wilson; Jason Reed; Gnankang S Napoe; Shari Piaskowski; Andy Szymanski; Jessica Furlott; Edna J Gonzalez; Levi J Yant; Nicholas J Maness; Gemma E May; Taeko Soma; Matthew R Reynolds; Eva Rakasz; Richard Rudersdorf; Adrian B McDermott; David H O'Connor; Thomas C Friedrich; David B Allison; Amit Patki; Louis J Picker; Dennis R Burton; Jing Lin; Lingyi Huang; Deepa Patel; Gwendolyn Heindecker; Jiang Fan; Michael Citron; Melanie Horton; Fubao Wang; Xiaoping Liang; John W Shiver; Danilo R Casimiro; David I Watkins
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Type I interferon suppresses virus-specific B cell responses by modulating CD8+ T cell differentiation.

Authors:  E Ashley Moseman; Tuoqi Wu; Juan Carlos de la Torre; Pamela L Schwartzberg; Dorian B McGavern
Journal:  Sci Immunol       Date:  2016-10-21

4.  Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection.

Authors:  Ivan Osokine; Laura M Snell; Cameron R Cunningham; Douglas H Yamada; Elizabeth B Wilson; Heidi J Elsaesser; Juan Carlos de la Torre; David Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

5.  Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection.

Authors:  Pablo Penaloza-MacMaster; Daniel L Barber; E John Wherry; Nicholas M Provine; Jeffrey E Teigler; Lily Parenteau; Stephen Blackmore; Erica N Borducchi; Rafael A Larocca; Kathleen B Yates; Hao Shen; W Nicholas Haining; Rami Sommerstein; Daniel D Pinschewer; Rafi Ahmed; Dan H Barouch
Journal:  Science       Date:  2015-01-16       Impact factor: 47.728

6.  Determinants of HIV-1 broadly neutralizing antibody induction.

Authors:  Peter Rusert; Roger D Kouyos; Claus Kadelka; Hanna Ebner; Merle Schanz; Michael Huber; Dominique L Braun; Nathanael Hozé; Alexandra Scherrer; Carsten Magnus; Jacqueline Weber; Therese Uhr; Valentina Cippa; Christian W Thorball; Herbert Kuster; Matthias Cavassini; Enos Bernasconi; Matthias Hoffmann; Alexandra Calmy; Manuel Battegay; Andri Rauch; Sabine Yerly; Vincent Aubert; Thomas Klimkait; Jürg Böni; Jacques Fellay; Roland R Regoes; Huldrych F Günthard; Alexandra Trkola
Journal:  Nat Med       Date:  2016-09-26       Impact factor: 53.440

7.  Influence of disulfide-stabilized structure on the specificity of helper T-cell and antibody responses to HIV envelope glycoprotein gp120.

Authors:  Denise Mirano-Bascos; N Kalaya Steede; James E Robinson; Samuel J Landry
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

8.  Race between retroviral spread and CD4+ T-cell response determines the outcome of acute Friend virus infection.

Authors:  Rebecca Pike; Andrew Filby; Mickaël J-Y Ploquin; Urszula Eksmond; Rute Marques; Inês Antunes; Kim Hasenkrug; George Kassiotis
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

Review 9.  Networking at the level of host immunity: immune cell interactions during persistent viral infections.

Authors:  Cherie T Ng; Laura M Snell; David G Brooks; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

10.  MyD88 negatively controls hypergammaglobulinemia with autoantibody production during bacterial infection.

Authors:  Anne Woods; Pauline Soulas-Sprauel; Benoit Jaulhac; Bérénice Arditi; Anne-Marie Knapp; Jean-Louis Pasquali; Anne-Sophie Korganow; Thierry Martin
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.